Co-Diagnostics, Inc. Common Stock
CODX Real Time Price USDRecent trades of CODX by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by CODX's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Methods of preventing non-specific reactions of nucleotide sequences Aug. 09, 2016
-
Patent Title: Detection primers for nucleic acid extension or amplification reactions Aug. 26, 2014
-
Patent Title: System and method for nucleic acids sequencing by phased synthesis Jun. 10, 2014
-
Patent Title: Waveguide-based detection system with scanning light source Mar. 18, 2014
-
Patent Title: Waveguide-based optical scanning systems Oct. 16, 2012
-
Patent Title: Optical scanning system May. 29, 2012
-
Patent Title: Optical scanning system May. 31, 2011
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of CODX in WallStreetBets Daily Discussion
Recent insights relating to CODX
Recent picks made for CODX stock on CNBC
ETFs with the largest estimated holdings in CODX
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view CODX Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.